Artificial Intelligence in Clinical Decision Support Market Global Report 2026

The artificial intelligence in clinical decision support market size has grown rapidly in recent years. It will grow from $0.96 billion in 2025 to $1.13 billion in 2026 at a compound annual growth rate (CAGR) of 17.5%. The growth in the historic period can be attributed to paper based clinical decision making, limited electronic health record adoption, fragmented patient data systems, high dependence on physician experience, slow integration of evidence based guidelines.

The artificial intelligence in clinical decision support market size is expected to see rapid growth in the next few years. It will grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to widespread adoption of real time clinical analytics, expansion of interoperable healthcare data ecosystems, increasing demand for personalized medicine support tools, rising focus on clinical safety and decision transparency, integration of multimodal patient data for precision diagnostics. Major trends in the forecast period include interoperable clinical data exchange frameworks, real world evidence driven clinical validation systems, clinician workflow integration and automation tools, patient centric personalized treatment recommendation systems, regulatory compliant clinical decision audit and documentation systems.

The increasing adoption of precision medicine approaches is expected to propel the growth of the artificial intelligence in clinical decision support market going forward. Precision medicine refers to a healthcare approach that customizes disease prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environmental factors. The increasing adoption of precision medicine approaches is driven by the rapid expansion of genomic research and the growing availability of large-scale patient data. Artificial intelligence in clinical decision support supports precision medicine approaches by analyzing complex genomic and clinical datasets to deliver personalized treatment recommendations, improve diagnostic accuracy, and enhance predictive healthcare outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, representing an increase from the six approved in 2022. Therefore, the increasing adoption of precision medicine approaches is driving the growth of the artificial intelligence in clinical decision support market.

Key companies operating in the artificial intelligence in clinical decision support market are focusing on integrating generative AI into clinical decision support, such as large language model-based healthcare assistants, to improve clinical workflow efficiency, automate medical documentation, and enhance personalized treatment recommendations. Large language model-based healthcare assistants are generative AI systems trained on extensive medical and clinical datasets that support healthcare professionals by interpreting patient information, generating clinical summaries, and delivering evidence-based recommendations in real time. For example, in October 2024, Microsoft Corporation, a US-based technology company, introduced Copilot for Healthcare, a generative AI-powered healthcare solution designed to streamline administrative and clinical processes. The solution integrates with electronic health records to generate clinical summaries, supports natural language voice dictation for medical documentation, and enables clinicians to access real-time medical insights through conversational AI capabilities.

In October 2024, VitalHub Corp., a Canada-based healthcare technology company, acquired MedCurrent Corporation for an undisclosed amount. Through this acquisition, VitalHub aimed to strengthen its clinical decision support capabilities and expand its healthcare software portfolio by integrating MedCurrent’s evidence-based imaging order support solutions into its platform offerings. MedCurrent Corporation is a Canada-based provider of clinical decision support solutions focused on improving the appropriateness of diagnostic imaging orders.

Major companies operating in the artificial intelligence in clinical decision support market are International Business Machines Corporation; Oracle Corporation; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; McKesson Corporation; Siemens Healthineers AG; Wolters Kluwer N.V.; Becton Dickinson and Company; Veradigm Inc.; NextGen Healthcare Inc.; Merative L.P.; Athenahealth Inc.; Agfa-Gevaert N.V.; Premier Inc.; Aidoc Medical Ltd.; Viz.ai Inc.; Persyst Development Corporation; Etiometry Inc.; BeeKeeperAI Inc.; Natus Medical Incorporated; Nuance Communications Inc.; Epic Systems Corporation; Medical Information Technology Inc. (MEDITECH); Enlitic Inc.; Qventus Inc.

North America was the largest region in the artificial intelligence in clinical decision support market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in clinical decision support market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence in clinical decision support market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in clinical decision support market includes revenues earned by entities by providing services such as predictive analytics, treatment recommendation systems, patient risk assessment, workflow optimization, and clinical data management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The artificial intelligence in clinical decision support market research report is one of a series of new reports that provides artificial intelligence in clinical decision support market statistics, including artificial intelligence in clinical decision support industry global market size, regional shares, competitors with a artificial intelligence in clinical decision support market share, detailed artificial intelligence in clinical decision support market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in clinical decision support industry. This artificial intelligence in clinical decision support market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.